Active Ingredient: BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
Proprietary Name: CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Dosage Form; Route of Administration: SUSPENSION; TOPICAL
Strength: 0.064%;0.005%
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A210765
Product Number: 001
Approval Date: May 11, 2020
Applicant Holder Full Name: COSETTE PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
